Back to Search
Start Over
Ibrutinib treatment in Waldenstrom's macroglobulinemia (WM): follow-up results of the phase 3 iNNOVATE (TM) study
- Publication Year :
- 2019
- Subjects :
- Health Sciences
Επιστήμες Υγείας
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.dedup.wf.001..1b37eaa30365259c560f67a1253ca37a